Explore our export-grade line of absorbable gauze, surgical sutures, and specialized wound closure consumables manufactured under strict ISO 13485 and CE compliance.
High-tensile, braided synthetic absorbable suture optimized for small animal surgical wound closure with rapid degradation profile.
Get a Quote
Coated PGA monofilament and braided suture designed for smooth tissue passage and reliable knot security during soft-tissue ligation.
Get a Quote
Breathable, waterproof silicone foam layer combined with absorptive matrix for high-exudate wound management and postoperative healing.
Get a Quote
Purified collagen chromic catgut and polyglactin sutures fitted with precision stainless-steel needles for rapid tissue absorption.
Get a Quote
Comprehensive operating theater suture kits featuring pre-threaded Polyglactin 910 formulations engineered for multi-specialty surgery.
Get a Quote
Engineered Polyglycolic Acid thread delivering 75% tensile retention at 14 days post-implantation, perfect for demanding orthopedic procedures.
Get a Quote
Direct-from-factory PGA sutures with silicone-coated atraumatic stainless steel needles, designed for high-volume tender agencies.
Get a Quote
Disposable sterile PGA suture assembly engineered for superior knot hold, minimal tissue drag, and predictable bio-absorption kinetics.
Get a QuoteUnderstanding the physiological cascade of Oxidized Regenerated Cellulose (ORC) in intraoperative bleeding control, tissue reactivity, and rapid absorption.
Our CE certified hemostatic gauze is manufactured through the controlled oxidation of rayon/pure cotton polymer, yielding precise concentrations of poly-anhydroglucuronic acid. When brought into contact with whole blood, the low pH environment triggers artificial clot matrix formation. Platelets rapidly adhere, swell, and aggregate without depending on systemic coagulation factors—making it exceptionally effective in heparinized patients.
Unlike native gelatin or collagen sponges, our oxidized regenerated cellulose matrix maintains an acidic micro-environment (pH < 4.0). Independent laboratory assays prove this local acidity exerts an immediate bactericidal effect against both Gram-positive and Gram-negative pathogens, including antibiotic-resistant strains such as MRSA, MRSE, and VRE, reducing surgical site infection (SSI) risks in contaminated operative fields.
The fibrous structure degrades into soluble glucuronic and glucose subunits via non-enzymatic hydrolytic cleavage. Clinical implantation data demonstrates full absorption within 7 to 14 days without granuloma formation or tissue encapsulation. This clean bio-resorption bypasses secondary removal procedures, lowering hospital readmission rates and facilitating clean tissue regeneration.
Operating under ISO 13485:2016, ISO 9001:2015, and WHO-GMP standards, our single-site production campus integrates polymer purification through to final sterile packaging.
Every single box of hemostatic gauze and surgical suture is produced within our automated Bengaluru manufacturing hub. From raw chemical oxidation, weaving, and ultrasonic cutting to sterile primary foil sealing and Ethylene Oxide (EO) sterilization, zero steps are outsourced. This guarantees 100% lot-to-lot traceability retrievable for over 11 years.
We supply turnkey regulatory dossiers for ministry of health registrations worldwide. Our technical export packs include the EU Declaration of Conformity, Free Sale Certificates (FSC), ISO 10993 cytotoxicity and hemocompatibility validation charts, real-time 5-year stability testing metrics, and multi-language Instructions for Use (IFU).
We empower regional medical supply brands, tender agents, and hospital network distributors with customized solutions. Tailor weave density, size dimensions (from 1"x1" dental pads to 4"x8" laparotomy packs), primary foil printing, GS1-128 UDI barcode generation, and multi-lingual outer carton artwork seamlessly.
High-purity raw cellulose is oxidized into uniform poly-anhydroglucuronic acid matrices.
Non-woven or knitted structure formulation to regulate porosity and fluid uptake speed.
Clean automated edge slitting eliminates loose fibers and potential foreign-body granulomas.
Hermetic nitrogen-flushed foil primary packaging prevents hydrolytic premature degradation.
Ethylene Oxide batch sterilization reaching guaranteed SAL 10⁻⁶ sterility assurance level.
A rigorous comparative analysis of absorbable hemostatic agents for surgical procurement evaluation.
| Biomaterial Parameter | Oxidized Regenerated Cellulose (ORC) Gauze | Absorbable Gelatin Sponge | Bovine Collagen Matrix | Chitosan Hemostatic Pad |
|---|---|---|---|---|
| Primary Composition | 100% Plant-Based Cellulose | Porcine Skin Gelatin | Bovine Tendon Collagen | Shrimp/Crustacean Chitin |
| Hemostasis Speed (In-Vivo) | 2 to 4 Minutes | 5 to 8 Minutes | 3 to 6 Minutes | 2 to 5 Minutes |
| Microbial Profile | Bactericidal (Low pH < 4.0) | Neutral (Supports Bacterial Growth) | Neutral (Potential Antigenicity) | Mild Bacteriostatic |
| Full Absorption Time | 7 to 14 Days | 4 to 6 Weeks | 8 to 12 Weeks | Non-Absorbable / Removal Reqd. |
| Immunological Risk | Zero Risk (Non-Animal Derived) | Prion / BSE Risk Profile | Zoonotic Disease & Allergy Risk | Shellfish Hypersensitivity |
| Handling Characteristics | Frayless, Can Be Cut & Sutured | Swellable, May Compress Nerves | Adheres to Surgical Gloves | Rigid when Dry |
*Data compiled from standardized USP/EP monograph benchmarks and controlled internal ISO 10993 trial validations.
Strategic insights for hospital purchasing networks, national health ministries, and medical supply importers navigating the next decade of surgical biomaterials.
Global regulatory bodies including the EU Commission (MDR 2017/745) and the US FDA are tightening surveillance over animal-derived medical devices due to BSE/TSE transmissible spongiform encephalopathy risks and bovine collagen hypersensitivity. Procurement agencies are rapidly replacing porcine gelatin and bovine collagen with synthetic or plant-derived oxidized regenerated cellulose, eliminating biological contagion vectors and simplifying regulatory approvals.
Post-operative tissue adhesions account for over 74% of abdominal re-operation complications. Future purchasing tenders increasingly specify "Dual-Function Hemostatic Gauze"—biomaterials that stop bleeding immediately while acting as a physical anti-adhesion barrier during the critical 7-day healing window. Our continuous R&D ensures our high-density knitted ORC formulations satisfy both fast hemostasis and tissue separation requirements.
The vulnerabilities exposed by global logistics disruptions have driven tender agencies to bypass multi-tier broker networks. Buyers now prioritize direct manufacturing partners offering single-site production, long-term raw material buffers, dynamic private labeling, and robust regulatory compliance. Direct factory contracting reduces sourcing costs by 30-45% while ensuring consistent stock buffers.
Direct answers for regulatory affairs officers, medical device importers, and surgical tender committees.
Accelerate your surgical product line with factory-direct pricing, guaranteed CE/ISO MDR regulatory dossiers, and fast export delivery to over 50 countries worldwide.
